Cite
A Single‐Dose, Open‐Label, Randomized, Two‐Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of Daprodustat.
MLA
Yamada, Masanori, et al. “A Single‐Dose, Open‐Label, Randomized, Two‐Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of Daprodustat.” Clinical Pharmacology in Drug Development, vol. 9, no. 8, Nov. 2020, pp. 978–84. EBSCOhost, https://doi.org/10.1002/cpdd.793.
APA
Yamada, M., Osamura, M., Ogura, H., Onoue, T., Wakamatsu, A., Numachi, Y., Caltabiano, S., & Mahar, K. M. (2020). A Single‐Dose, Open‐Label, Randomized, Two‐Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of Daprodustat. Clinical Pharmacology in Drug Development, 9(8), 978–984. https://doi.org/10.1002/cpdd.793
Chicago
Yamada, Masanori, Minori Osamura, Hirofumi Ogura, Tomohiro Onoue, Akira Wakamatsu, Yotaro Numachi, Stephen Caltabiano, and Kelly M. Mahar. 2020. “A Single‐Dose, Open‐Label, Randomized, Two‐Way Crossover Study in Healthy Japanese Participants to Evaluate the Bioequivalence and the Food Effect on the Pharmacokinetics of Daprodustat.” Clinical Pharmacology in Drug Development 9 (8): 978–84. doi:10.1002/cpdd.793.